Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients.

Trial Profile

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2015

At a glance

  • Drugs Aliskiren (Primary) ; Ramipril
  • Indications Isolated systolic hypertension
  • Focus Therapeutic Use
  • Acronyms ALIAS
  • Sponsors Novartis
  • Most Recent Events

    • 23 Aug 2011 Actual end date (January 2011) added as reported by ClinicalTrials.gov.
    • 23 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top